| LINE ITEM (USD / %) | FY 2025
FILED 2025-09-30 | FY 2024
FILED 2024-09-30 | FY 2023
FILED 2023-09-30 |
|---|---|---|---|
| Revenue (Total Sales) | $1.50B | $1.80B | $1.88B |
| YoY Revenue Growth % | -16.6% | -4.5% | — |
| Gross Profit | $507.6M | $529.7M | — |
| Gross Margin % | 33.9% | 29.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $75.5M | -$12.3M | $88.1M |
| Operating Margin % | 5.0% | -0.7% | 4.7% |
| Net Income (GAAP) | -$24.5M | -$59.7M | $39.3M |
| EBITDA (Normalized) | $104.1M | $23.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$23.6M | $79.3M | $79.5M |
| Capital Expenditures (CapEx) | $35.8M | $45.2M | — |
| Free Cash Flow (FCF) | -$59.4M | $34.1M | $79.5M |
| FCF Margin % | -4.0% | 1.9% | 4.2% |
| Return on Invested Capital (ROIC %) | 5.7% | -0.8% | — |
| Cash & Short-Term Equivalents | $31.4M | $33.5M | — |
| Total Debt (Short + Long Term) | $529.8M | $802.0M | — |
| Total Stockholders' Equity | $543.2M | $413.4M | — |